| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc. (APGE) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. APGE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.13M | $94.07M | - | |
| Dir | 365.9K | $30.38M | - | |
| Other | 228.3K | $18.95M | - | |
| CFO | 179.4K | $14.89M | - | |
| Dir | 14.5K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 | Dambkowski Carl51 | Chief Medical Officer | Sell | 7,335 | $40.67 | $298,335.79 | -0.8% | +42.6% | -11.9% | |
| Jul 5, 2024 | Henderson Michael Thomas58 | Chief Executive Officer | Sell | 15,000 | $37.26 | $558,900.00 | -1.0% | +49.5% | +3.2% | |
| Jul 3, 2024 | Dambkowski Carl51 | Chief Medical Officer | Sell | 5,995 | $37.60 | $225,417.96 | -1.0% | +52.8% | +26.6% | |
| Jul 13, 2023 | Fairmount Funds Management LLC73 | Director | Buy | 2,941,176 | $17.00 | $49,999,992.00 | New | -4.1% | +126.2% | |
| Jul 13, 2023 | Shah Nimish P | Director | Buy | 1,750,000 | $17.00 | $29,750,000.00 | New | -4.1% | +126.2% |